ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
Artrya Ltd
$4.820
+$0.390 (+8.80%)
Day Range
$4.420 – $4.885
52 Week Range
$1.225 – $6.490
Volume
601.35K
Avg Volume (10D)
1.06M
Market Cap
$785.48M
Price Chart
Market Statistics
Open$4.460
Previous Close$4.430
Day High$4.885
Day Low$4.420
52 Week High$6.490
52 Week Low$1.225
Valuation
Market Cap785.48M
Shares Outstanding162.96M
Price to Book7.86
Trading Activity
Volume601.35K
Value Traded2.85M
Bid$4.730 × 1,924
Ask$4.880 × 1,290
Performance
1 Day1.37%
5 Day10.17%
13 Week-0.22%
52 Week296.43%
YTD-5.73%
Technical Indicators
RSI (14)48.63
50-Day SMA$5.114
200-Day SMA$4.112
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]